Skip to content

Jerome Beck

3 papers in the library · 152 citations · publishing 1986-2019

Papers

Sort Most recent Most cited

Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction: Qualitative Follow-Up Study of a Clinical Trial for Individuals with Treatment-Resistant PTSD

Journal of Psychoactive Drugs March 8, 2019 William P. Barone, Jerome Beck, Michiko Mitsunaga-Whitten et al. 63 citations

We present select findings from a long-term follow-up qualitative study of MDMA-assisted psychotherapy for veterans, firefighters, and police officers suffering from chronic, treatment-resistant PTSD. Semi-structured qualitative interviews were conducted at participants' one-year follow-up after a recently completed phase 2 clinical trial. Available interviews from 19 of 24 participants were...

New Age Seekers: MDMA Use as an Adjunct to Spiritual Pursuit

Journal of Psychoactive Drugs July 1, 1991 Lynne Watson, Jerome Beck 32 citations

The use of MDMA as an adjunct to spiritual pursuit among New Ager seekers is examined. These study respondents indicated that social worlds greatly influenced which qualities of the MDMA experience were most pursued and valued. In contrast to recreationally oriented respondents, who saw minimal long-term benefits accruing from MDMA use, New Agers typically believed that carefully planned...

Designer Drug Confusion: A Focus on MDMA

Journal of Drug Education September 1, 1986 Jerome Beck, Patricia Morgan 57 citations

This article discusses the competing definitions and issues surrounding the various desgner drugs, but is primarily devoted t o an examination of MDMA, an increasingly popular substance often labeled as a designer drug. Also known as “Ecstasy” or “Adam,” MDMA possesses both stimulant and psychedelic properties which combine to produce a unique effect desired by many users. The authors offer a...